Working capital decreased 87.6%
Working capital changed -87.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$213.4M→$26.5M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CHPT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Noncurrent long-term debt decreased 29.1%
Noncurrent long-term debt changed -29.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$309.4M→$219.5M4 prior comparisons
Total assets decreased 20.1%
Total assets changed -20.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$870.3M→$695.7M4 prior comparisons
Working capital / assets moved 2072 bp lower
Working capital / assets changed -2072 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
24.53%→3.80%4 prior comparisons
Operating income increased 42.3%
Operating income changed +42.3% from the comparable as-filed period.
-$59.0M→-$34.1M2 prior comparisons
Operating margin moved 3048 bp higher
Operating margin changed +3048 basis points from the comparable as-filed period.
-59.82%→-29.34%2 prior comparisons
Inventory decreased 15.5%
Inventory changed -15.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$212.4M→$179.5M4 prior comparisons
Current assets decreased 27.6%
Current assets changed -27.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$533.4M→$386.4M4 prior comparisons
Gross margin moved 528 bp higher
Gross margin changed +528 basis points from the comparable as-filed period.
31.17%→36.44%2 prior comparisons
Cash & equivalents decreased 50.9%
Cash & equivalents changed -50.9% from the comparable as-filed period.
$194.1M→$95.3M3 prior comparisons
Free-cash-flow proxy increased 30.2%
Free-cash-flow proxy changed +30.2% from the comparable as-filed period.
-$7.5M→-$5.2M3 prior comparisons
Operating cash flow increased 31.2%
Operating cash flow changed +31.2% from the comparable as-filed period.
-$6.2M→-$4.2M3 prior comparisons
Inventory / revenue moved 6083 bp lower
Inventory / revenue changed -6083 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
215.44%→154.61%2 prior comparisons
Revenue increased 17.7%
Revenue changed +17.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$98.6M→$116.1M2 prior comparisons
Stock-based compensation decreased 39.8%
Stock-based compensation changed -39.8% from the comparable as-filed period.
$18.2M→$11.0M2 prior comparisons
Gross profit increased 37.7%
Gross profit changed +37.7% from the comparable as-filed period.
$30.7M→$42.3M2 prior comparisons
SBC / revenue moved 903 bp lower
SBC / revenue changed -903 basis points from the comparable as-filed period.
18.48%→9.45%2 prior comparisons
Shares outstanding increased 15.0%
Shares outstanding changed +15.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
23,353,260→26,850,3248 prior comparisons
Current ratio decreased 35.6%
Current ratio changed -35.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
1.67→1.074 prior comparisons
Receivables / revenue moved 2270 bp lower
Receivables / revenue changed -2270 basis points from the comparable as-filed period.
97.39%→74.69%2 prior comparisons
R&D / revenue moved 908 bp lower
R&D / revenue changed -908 basis points from the comparable as-filed period.
37.00%→27.92%2 prior comparisons
Free-cash-flow margin moved 308 bp higher
Free-cash-flow margin changed +308 basis points from the comparable as-filed period.
-7.56%→-4.48%2 prior comparisons
Operating cash-flow margin moved 259 bp higher
Operating cash-flow margin changed +259 basis points from the comparable as-filed period.
-6.24%→-3.65%2 prior comparisons
Current liabilities increased 12.5%
Current liabilities changed +12.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$320.0M→$359.9M4 prior comparisons
Research & development decreased 11.2%
Research & development changed -11.2% from the comparable as-filed period.
$36.5M→$32.4M2 prior comparisons
Capital expenditure decreased 25.4%
Capital expenditure changed -25.4% from the comparable as-filed period.
$1.3M→$968,0003 prior comparisons
Trade receivables decreased 9.7%
Trade receivables changed -9.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$96.0M→$86.7M4 prior comparisons
Capex / revenue moved 48 bp lower
Capex / revenue changed -48 basis points from the comparable as-filed period.
1.32%→0.83%2 prior comparisons
Operating margin moved 883 bp higher
Operating margin changed +883 basis points from the comparable as-filed period.
-55.14%→-46.31%3 prior comparisons
Cash & equivalents decreased 51.1%
Cash & equivalents changed -51.1% from the comparable as-filed period.
$195.9M→$95.8M2 prior comparisons
Net income increased 24.4%
Net income changed +24.4% from the comparable as-filed period.
-$57.1M→-$43.2M2 prior comparisons
Inventory / revenue moved 1760 bp lower
Inventory / revenue changed -1760 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
217.56%→199.96%2 prior comparisons
SBC / revenue moved 789 bp lower
SBC / revenue changed -789 basis points from the comparable as-filed period.
18.29%→10.41%3 prior comparisons
Stock-based compensation decreased 40.7%
Stock-based compensation changed -40.7% from the comparable as-filed period.
$17.9M→$10.6M3 prior comparisons
Free-cash-flow proxy decreased 10.8%
Free-cash-flow proxy changed -10.8% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
-$34.0M→-$37.7M6 prior comparisons
Operating income increased 12.4%
Operating income changed +12.4% from the comparable as-filed period.
-$53.8M→-$47.2M3 prior comparisons
Operating cash flow decreased 10.9%
Operating cash flow changed -10.9% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
-$33.0M→-$36.6M6 prior comparisons
Revenue increased 4.3%
Revenue changed +4.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$97.6M→$101.8M3 prior comparisons
Gross margin moved 43 bp higher
Gross margin changed +43 basis points from the comparable as-filed period.
28.66%→29.09%3 prior comparisons
Research & development increased 6.2%
Research & development changed +6.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$33.5M→$35.6M3 prior comparisons
Inventory decreased 4.2%
Inventory changed -4.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$212.4M→$203.6M3 prior comparisons
Capex / revenue moved 3 bp higher
Capex / revenue changed +3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.09%→1.12%2 prior comparisons
Capital expenditure increased 7.3%
Capital expenditure changed +7.3% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 5 consecutive comparable moves in the opposite direction.
$1.1M→$1.1M6 prior comparisons
Gross profit increased 5.8%
Gross profit changed +5.8% from the comparable as-filed period.
$28.0M→$29.6M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.